Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044518 · ClinicalTrials.gov registry record · NA
The Clinical Application of Apple AirPods Pro 2 vs. Hearing Aids
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT07044518: Completed NA study, sponsored by University of Arizona.
NCT07044518 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044518, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether the Apple AirPods Pro 2 can accurately test hearing and provide helpful amplification, like a traditional hearing aid, in adults with hearing loss. The main questions it aims to answer are: * Can the AirPods Pro 2 hearing test give similar results to a standard hearing test done in a sound booth by an audiologist? * Can the AirPods Pro 2 provide amplification (make sounds louder) in a way that matches what a traditional hearing aid would provide? Researchers will compare the AirPods Pro 2 results to standard hearing tests and hearing aid fittings to see if they perform in a similar way. Participants will: * Take a standard hearing test in a sound booth * Use the Apple Hearing Test with AirPods Pro 2 * Have the loudness of the AirPods and a traditional hearing aid measured and compared using special equipment
Primary Outcome
measure that evaluates hearing threshold at octave frequencies between 250 to 8000Hz; measured in dB HL.
Interventions
- DEVICE Over-the-Counter Hearing Aid
- DEVICE Hearing aid, air conduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2025-12-04 |
| Phase | NA |
What the finished NCT07044518 record still lists
NCT07044518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Over-the-Counter Hearing Aid is the first listed.
NCT07044518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07044518 about?
NCT07044518 is a clinical study titled "The Clinical Application of Apple AirPods Pro 2 vs. Hearing Aids". The goal of this clinical trial is to learn whether the Apple AirPods Pro 2 can accurately test hearing and provide helpful amplification, like a traditional hearing aid, in adults with hearing loss. The main questions it aims to answer are: * Can the AirPods Pro 2 hearing test give similar results...
What is the current status of trial NCT07044518?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2025-09-11. Estimated completion is 2025-12-04.
What interventions are being tested in trial NCT07044518?
The interventions under investigation include: Over-the-Counter Hearing Aid (DEVICE), Hearing aid, air conduction (DEVICE).
Who is sponsoring clinical trial NCT07044518?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07044518's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI